Inflammation: A Key Contributor to the Genesis and Progression of Chronic Kidney Disease

被引:47
|
作者
Qian, Qi [1 ]
机构
[1] Mayo Clin, Coll Med, Dept Med, Div Nephrol & Hypertens, 200 First St SW, Rochester, MN 55905 USA
关键词
GLOMERULAR-FILTRATION-RATE; AMMONIA TRANSPORTER FAMILY; SERUM BICARBONATE LEVELS; ORAL SODIUM-BICARBONATE; ACID-BASE-BALANCE; GUT MICROBIOME; METABOLIC-ACIDOSIS; HYPERTENSIVE NEPHROPATHY; STOP HYPERTENSION; NORMAL RANGE;
D O I
10.1159/000479257
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
It has become apparent that inflammation and inflammatory reactions can evoke renal injury and promote chronic kidney disease (CKD) progression. Under physiological condition, intrarenal vascular distribution is heterogeneous, and medulla is hypoxic. To avoid energy deprivation in the low pO(2) regions of the kidney, an array of hormones, autocoids, and vasoactive substances, including medullipin, prostaglandins, endothelins, nitric oxide, angiotensin II, kinins, and adenosine, tonically regulates the microvasculature to ensure a perfect match of the microcirculation (O-2 supply) and renal tubules (O-2 demand). Inflammation, systemic or intrarenal, not only can abolish the microvascular response to its regulators, but also induces an array of tubular toxins, including reactive oxygen species, leading to tubular injury, nephron dropout, and onset of CKD. Positive acid balance, electrolyte alterations, and intestinal dysbiosis can perpetuate CKD progression. Understanding the role of inflammation in the genesis and progression of CKD will foster the development of strategies to prevent and treat the underlying inflammation and improve CKD outcomes. (c) 2017 S. Karger AG, Basel
引用
收藏
页码:72 / 83
页数:12
相关论文
共 50 条
  • [1] Chronic Inflammation and Progression of Diabetic Kidney Disease
    Furuya, Fumihiko
    Ishii, Toshihisa
    Kitamura, Kenichiro
    [J]. CKD-ASSOCIATED COMPLICATIONS: PROGRESS IN THE LAST HALF CENTURY, 2019, 198 : 33 - 39
  • [2] Biomarkers of inflammation and progression of chronic kidney disease
    Tonelli, M
    Sacks, F
    Pfeffer, M
    Jhangri, GS
    Curhan, G
    [J]. KIDNEY INTERNATIONAL, 2005, 68 (01) : 237 - 245
  • [3] Inflammation in chronic kidney disease: role in the progression of renal and cardiovascular disease
    Douglas M. Silverstein
    [J]. Pediatric Nephrology, 2009, 24 : 1445 - 1452
  • [4] Inflammation in chronic kidney disease: role in the progression of renal and cardiovascular disease
    Silverstein, Douglas M.
    [J]. PEDIATRIC NEPHROLOGY, 2009, 24 (08) : 1445 - 1452
  • [5] Chronic Inflammation in Chronic Kidney Disease Progression: Role of Nrf2
    Stenvinkel, Peter
    Chertow, Glenn M.
    Devarajan, Prasad
    Levin, Adeera
    Andreoli, Sharon P.
    Bangalore, Sripal
    Warady, Bradley A.
    [J]. KIDNEY INTERNATIONAL REPORTS, 2021, 6 (07): : 1775 - 1787
  • [6] Chronic kidney disease is a key risk factor for aortic stenosis progression
    Candellier, Alexandre
    Bohbot, Yohann
    Pasquet, Agnes
    Diouf, Momar
    Vermes, Emmanuelle
    Goffin, Eric
    Gun, Mesut
    Peugnet, Fanny
    Henaut, Lucie
    Rusinaru, Dan
    Mentaverri, Romuald
    Kamel, Said
    Choukroun, Gabriel
    Vanoverschelde, Jean-Louis
    Tribouilloy, Christophe
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 (12) : 2776 - 2785
  • [7] Is hyperhomocysteinemia a contributor to atherosclerosis in chronic kidney disease patients?
    Suliman, ME
    Stenvinkel, P
    Lindholm, B
    [J]. NEPHRON CLINICAL PRACTICE, 2005, 101 (04): : C187 - C189
  • [8] Chronic Inflammation in Chronic Kidney Disease
    Yan, Zhipeng
    Shao, Tingting
    [J]. NEPHRON, 2024, 148 (03) : 143 - 151
  • [9] Chronic kidney disease progression
    Eddy, Allison A.
    Neilson, Eric G.
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2006, 17 (11): : 2964 - 2966
  • [10] Progression in chronic kidney disease
    Eddy, AA
    [J]. ADVANCES IN CHRONIC KIDNEY DISEASE, 2005, 12 (04) : 353 - 365